These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 32943616)

  • 1. DRAM1 regulates autophagy flux through lysosomes.
    Zhang XD; Qi L; Wu JC; Qin ZH
    PLoS One; 2013; 8(5):e63245. PubMed ID: 23696801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.
    Kondapalli KC; Llongueras JP; Capilla-González V; Prasad H; Hack A; Smith C; Guerrero-Cázares H; Quiñones-Hinojosa A; Rao R
    Nat Commun; 2015 Feb; 6():6289. PubMed ID: 25662504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRAM1 increases the secretion of PKM2-enriched EVs from hepatocytes to promote macrophage activation and disease progression in ALD.
    Tan J; Zhang J; Wang M; Wang Y; Dong M; Ma X; Sun B; Liu S; Zhao Z; Chen L; Jin W; Liu K; Xin Y; Zhuang L
    Mol Ther Nucleic Acids; 2022 Mar; 27():375-389. PubMed ID: 35036051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway.
    Yang Y; Zhu L; Liu J; Yu P; Que Z; Li Y; Li H; Tian J
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1851-1854. PubMed ID: 37723875
    [No Abstract]   [Full Text] [Related]  

  • 5. Exercise-activated hepatic autophagy combined with silymarin is associated with suppression of apoptosis in rats subjected to dexamethasone induced- fatty liver damage.
    Andani FM; Talebi-Garakani E; Ashabi G; Ganbarirad M; Hashemnia M; Sharifi M; Ghasemi M
    Mol Biol Rep; 2024 Aug; 51(1):928. PubMed ID: 39172304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting dysregulated phago-/auto-lysosomes in Sertoli cells to ameliorate late-onset hypogonadism.
    Deng Z; Zhao L; Li S; Chen X; Ling X; Zheng J; Yu K; Xu J; Yao C; Han S; Liang J; Feng H; Wu L; Li P; Tian R; Jing T; Tang Y; Dai Y; Yan M; Wang C; Li Z; Zhou Z
    Nat Aging; 2024 May; 4(5):647-663. PubMed ID: 38649614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenophagy receptors Optn and p62 and autophagy modulator Dram1 independently promote the zebrafish host defense against
    Xie J; Meijer AH
    Front Cell Infect Microbiol; 2023; 13():1331818. PubMed ID: 38264729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
    Zhou J; Li H; Wu B; Zhu L; Huang Q; Guo Z; He Q; Wang L; Peng X; Guo T
    Sci Rep; 2024 Jan; 14(1):1860. PubMed ID: 38253629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Association between the Autophagy Markers LC3B,
    Danish F; Qureshi MA; Mirza T; Amin W; Sufiyan S; Naeem S; Arshad F; Mughal N
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
    Xin Y; Jiang Q; Liu C; Qiu J
    Aging (Albany NY); 2023 Nov; 15(21):12225-12250. PubMed ID: 37925175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARHGAP4 promotes leukemogenesis in acute myeloid leukemia by inhibiting DRAM1 signaling.
    Qi Y; Hu M; Han C; Wang J; Chen F; Guo H; She Y; Zhang M; Zhang J; Zhao Z; Xie H; Wang S; Chen M; Wang J; Zeng D
    Oncogene; 2023 Aug; 42(34):2547-2557. PubMed ID: 37443303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker.
    de Araújo RA; da Luz FAC; da Costa Marinho E; Nascimento CP; de Andrade Marques L; Delfino PFR; Antonioli RM; Araújo BJ; da Silva ACAL; Dos Reis Monteiro MLG; Neto MB; Silva MJB
    Ecancermedicalscience; 2022; 16():1431. PubMed ID: 36158981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy-Related Gene Signature Highlights Metabolic and Immunogenic Status of Malignant Cells in Non-Small Cell Lung Cancer Adenocarcinoma.
    Leonardi L; Siberil S; Alifano M; Cremer I; Joubert PE
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma.
    Li X; Dai Z; Wu X; Zhang N; Zhang H; Wang Z; Zhang X; Liang X; Luo P; Zhang J; Liu Z; Zhou Y; Cheng Q; Chang R
    Front Immunol; 2022; 13():749241. PubMed ID: 35529878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation.
    Xue Y; Zhang J; Hou J; Wang X
    J Oncol; 2022; 2022():4402536. PubMed ID: 35222643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer.
    Zheng M; Hu Y; Gou R; Li S; Nie X; Li X; Lin B
    Mol Ther Oncolytics; 2021 Sep; 22():294-306. PubMed ID: 34553020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR.
    Geng J; Zhang R; Yuan X; Xu H; Zhu Z; Wang X; Wang Y; Xu G; Guo W; Wu J; Qin ZH
    Cell Death Dis; 2020 Sep; 11(9):768. PubMed ID: 32943616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer.
    Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
    Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
    Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.